Objective: Fine-needle aspiration (FNA) cytology is a safe and cost-effective technique for the diagnosis of lymphoproliferative processes, especially when correlated with clinical and imaging studies. However, cytology alone may be unable to detect a lymphoid neoplastic process, as architectural features are less obvious than in histologic preparations and, in certain cases, reactive processes may mimic lymphoma. Flow cytometry (FC) has been recognized as an important ancillary technique in the diagnosis of lymphoid neoplasms and it can be used in conjunction with FNA in the evaluation of lymphoproliferative processes. Study Design: We performed a review of the published literature concerning FC applied to the detection of salivary glands and thyroid lymphoproliferative processes, which are frequently related to autoimmune diseases and difficult to diagnose by cytomorphology alone. Results: FC is able to detect and subtype non-Hodgkin lymphomas and may contribute to the exclusion of a neoplastic process in cytologically unclear cases. Conclusions: FC can be successfully applied in the differential diagnosis of lymphoproliferative processes in the head and neck region. The FNA-FC combined approach can reduce time to therapy and may prevent unnecessary surgical biopsies.

1.
Rao DS, Daid JW: Small lymphoid proliferations in extranodal locations. Arch Pathol Lab Med 2007;131:383-396.
2.
Vannata B, Zucca E: Primary extranodal B-cell lymphoma: current concepts and treatment strategies. Chin Clin Oncol 2015;4:1-17.
3.
Tan LH: A practical approach to the understanding and diagnosis of lymphoma: an assessment of the WHO classification based on immunoarchitecture and immuno-ontogenic principles. Pathology 2009;41:305-326.
4.
Jaffe ES, Harris NL, Stein H, Isaacson PG: Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008;11:4384-4399.
5.
Jaffe ES, Harris NL, Stein H, Vardiman JW: Tumours of the Haematopoietic and Lymphoid Tissues. World Health Classification of Tumours. Lyon, IARC Press, 2001.
6.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, ed 4. Lyon, IARC Press, 2008.
7.
Craig FE, Foon KA: Flow cytometric immunophenotyping for haematologic neoplasms. Blood 2008;111:3941-3967.
8.
Neskoromna-Jedrejczak A, Tyndorf M, Arkuszewski P, Kobos J: Head and neck lymphomas - diagnostic difficulties. Polsky Przeglad Chirurgiczny 2012;84:113-118.
9.
De Tute RM: Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies. Histopathology 2011;58:90-105.
10.
Demurtas A, Accinelli G, Pacchioni D, Godio L, Novero D, Bussolati G, Palestro G, Papotti M, Stacchini A: Utility of flow cytometry immunophenotyping in fine-needle aspirate cytologic diagnosis of non-Hodgkin lymphoma: a series of 252 cases and review of the literature. Appl Immunohistochem Mol Morphol 2010;18:311-322.
11.
Stacchini A, Carucci P, Pacchioni D Accinelli G, Demurtas A, Aliberti S, Bosco M, Bruno M, Balbo Mussetto A, Rizzetto M, Bussolati G, De Angelis C: Diagnosis of deep-seated lymphomas by endoscopic ultrasound-guided fine needle aspiration combined with flow cytometry. Cytopathology 2012;23:50-56.
12.
Demurtas A, Stacchini A, Aliberti S, Chiusa L, Chiarle R, Novero D: Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin's lymphomas: a retrospective evaluation of 1,792 cases. Cytometry B Clin Cytom 2013;84:82-95.
13.
Stacchini A, Demurtas A, Aliberti S: Immunophenotyping of paucicellular samples. Curr Protoc Cytom 2014;68:9.46.1-14.
14.
Johansson U, Bloxham D, Couzens S, Jesson J, Morilla R, Erber W, Macey M: Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology. Br J Haematol 2014;165:455-488.
15.
Calvo KR, McCoy CS, Stetler-Stevenson M: Flow cytometry immunophenotyping of hematolymphoid neoplasia. Methods Mol Biol 2011;699:295-316.
16.
Li S, Eshleman JR, Borowitz MJ: Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma. Am J Clin Pathol 2002;118:229-234.
17.
Stacchini A, Demurtas A, Aliberti S, Francia di Celle P, Godio L, Novero D: The usefulness of flow cytometric CD10 detection in the differential diagnosis of peripheral T-cell lymphomas. Am J Clin Pathol 2007;128:854-864.
18.
Harris NL: Lymphoid proliferations of the salivary glands. Am J Clin Pathol 1999;111:S94-S103.
19.
Feinstein AJ, Ciarleglio MM, Cong X, Otremba MD, Judson BL: Parotid gland lymphoma: prognostic analysis of 2140 patients. Laryngoscope 2013;123:1199-1203.
20.
Yanagawa N, Osakabe M, Furuse H, Maeda K, Tamura G: Peripheral T-cell lymphoma arising from an intraglandular lymph node in the parotid gland: a case report and literature rewiew. Pathol Int 2012;62:60-64.
21.
Solans-Laquè R, Lopez-Hernadez A, Bosch-Gil JA, Palacios A, Campillo M, Vilardes-Tarres M: Risk, predictors, and clinical characteristics of lymphoma development in primay Sjögren's syndrome. Semin Arthritis Rheum 2011:41:415-423.
22.
Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM: Increased risk of lymphomas in sicca syndrome. Ann Intern Med 1978;89:888-892.
23.
Abbondanzo SL: Extranodal marginal-zone B-cell lymphoma of the salivary gland. Ann Diagn Pathol 2001;5:246-254.
24.
Schwock J, Geddie R: Diagnosis of B-cell non Hodgkin lymphomas with small-/intermediate-sized cells in cytopathlogy. Patholog Res Int 2012;2012:164934.
25.
Crapanzano JP: Cytologic findings of marginal zone lymphoma. Cancer Cytopathol 2003;99:301-309.
26.
Cha I, Long SR, Ljung BM, Miller TR: Low-grade lymphoma of mucosa-associated tissue in the parotid gland: a case report of fine-needle aspiration cytology diagnosis using flow cytometric immunophenotyping. Diagn Cytopathol 1997;16:345-349.
27.
Mayall F, Dray M, Stanley D, Harrison B, Allen R: Immunoflow cytometry and cell block immunohistochemistry in the FNA diagnosis of lymphoma: a review of 73 consecutive cases. J Clin Pathol 2000;53:451-457.
28.
Mayall F, Darlington A, Harrison B: Fine-needle aspiration cytology in the diagnosis of uncommon types of lymphoma. J Clin Pathol 2003;56:821-825.
29.
Zeppa P, Marino G, Troncone G, et al: Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions. Cancer 2004;102:55-65.
30.
Zeppa P, Vigliar E, Cozzolino I, et al: Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better? Cytopathology 2010;21:300-310.
31.
Schmid S, Tinguely M, Cione P, Moch H, Bode B: Flow cytometry as an accurate tool to complement fine needle aspiration cytology in the diagnosis of low grade malignant lymphomas. Cytopathology 2011;22:397-406.
32.
Barrena S, Almeida J, Garcia-Macia M, et al: Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas. Histopathology 2011;58:906-918.
33.
Orita Y, Sato Y, Kondo E, et al: Minimally invasive procedure for accurate diagnosis of mucosa-associated lymphoid tissue lymphoma of head and neck. Jpn J Clin Oncol 2012;42:325-330.
34.
Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, Veltri A, Maletta F, Molinaro L, Novero D: Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology 2014;25:231-240.
35.
Laane E, Tani E, Björklund E, Elmberger G, Everaus H, Skoog L, Porwit-MacDonald A: Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma. Cytometry B Clin Cytom 2005;64:34-42.
36.
Yanagawa N, Osakabe M, Furuse H, Maeda K, Tamura G: Peripheral T-cell lymphoma arising from an intraglandular lymph node in the parotid gland: a case report and literature rewiew. Pathol Int 2012;62:60-64.
37.
Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du MQ, Isaacson PG, Dogan A: Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002;99:627-633.
38.
Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, Berger F, Ducottet X, Martin C, Salles G, Orgiazzi J, Coiffier B: Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002;87:105-111.
39.
Aozasa K: Hashimoto's thyroiditis as a risk factor of thyroid lymphoma. Acta Pathol Jpn 1990;40:459-468.
40.
Walsh S, Lowery AJ, Evoy D, McDermott EW, Prichard RS: Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. Oncologist 2013;18:994-1003.
41.
Swart GJ, Wright C, Brundyn K, Mansvelt E, du Plessis M, ten Oever D, Jacobs P: Fine needle aspiration biopsy and flow cytometry in the diagnosis of lymphoma. Transfus Apher Sci 2007;37:71-79.
42.
Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, Gazzera C, Veltri A, Sapino A, Papotti M, Freddi M, Palestini N, Sisto G, Novero D: Utility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom 2015;88:320-329.
43.
Kandil E, Safah H, Noureldine S, Khalek MA, Waddr J, Goswami M, Friedlandel P: Burkitt-like lymphoma arising in the thyroid gland. Am J Med Sci 2012;343:103-105.
44.
Matsubayashi S, Tamai H, Morita T, Fukata S, Matsuzuka F, Suzuki T, Kuma K, Nagataki S, Volpé R: Hashimoto's thyroiditis manifesting monoclonal lymphocytic infiltration. Clin Exp Immunol 1990;79:170-174.
45.
Dunphy CH, Ramos R: Combining fine-needle aspiration and flow cytometric immunophenotyping in evaluation of nodal and extranodal sites for possible lymphoma: a retrospective review. Diagn Cytopathol 1997;16:200-206.
46.
Fujikawa M, Okamura K, Sato K, Mizokami T, Tanabe S, Ikenoue H, Okamura S, Ohta M, Fujishima M: Usefulness of surface phenotype study of intrathyroidal lymphocytes obtained by fine needle aspiration cytology in autoimmune thyroid disease and malignant lymphoma of the thyroid. Clin Endocrinol (Oxf) 1998;49:191-196.
47.
Cha C, Chen H, Westra WH, Udelsmann R: Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration? Ann Surg Oncol 2002;9:298-302.
48.
Al Marzooq YM, Chopra R, Younnis M, Al-Mulhim AS, Al-Mommatten M, Al-Omran SH: Thyroid low-grade B-cell lymphoma (MALT-type) with extreme plasmacytic differentiation: report of a case diagnosed by fine-needle aspiration and flow cytometric study. Diagn Cytopathol 2004;31:52-56.
49.
Chen HI, Akpolat I, Modr DR, Lopez-Terrada D, De Leon AP, Luo Y, Jorgensen J, Schwartz MR, Chang CC: Restricted κ/λ light chain ratio by flow cytometry in germinal center B cells in Hashimoto thyroiditis. Am J Clin Pathol 2006;125:42-48.
50.
Kalinyak JE, Kong CS, McDougall IR: Burkitt's lymphoma presenting as a rapidly growing thyroid mass. Thyroid 2006;10:1053-1057.
51.
Gupta R, Naseem S, Kashyap R, Paul L: Role of fine-needle aspirate immunophenotyping by flow cytometry in rapid diagnosis of lymphoproliferative disorders. Diagn Cytopathol 2007;35:381-385.
52.
Zeppa P, Cozzolino I, Peluso AL, Troncone G, Lucariello A, Picardi M, Carella C, Pane F, Vetrani A, Palombini L: Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis. Cancer Cytopathol 2009;117:174-184.
53.
Morgen EK, Geddie W, Boerner S, Bailey D, Gilda da Cunha S: The role of fine-needle aspiration in the diagnosis of thyroid lymphoma: a retrospective study of nine cases and review of published series. J Clin Pathol 2010;63:129-133.
54.
Vigliar E, Caleo A, Vitale M, Di Crescenzo V, Garzi A, Zeppa P: Early cytological diagnosis of extranodal stage I, primary thyroid non-Hodgkin lymphoma in elderly patients: report of two cases and review of the literature. BMC Surg 2013;13(suppl 2):S49.
55.
Caleo A, Vigliar E, Vitale M, Di Crescenzo V, Cinelli M, Carlomagno C, Garzi A, Zeppa P: Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients. BMC Surg 2013;13(suppl 2):S41.
56.
Boonyaarunnate T, Olson MT, Ali SZ: Impact of flow cytometry in thyroid cytopathology. Acta Cytol 2013;57:562-566.
57.
Adamczewski Z, Stasiołek M, Dedecjus M, Smolewski P, Lewiński A: Flow cytometry in the differential diagnostics of Hashimoto's thyroiditis and MALT lymphoma of the thyroid. Endokrynol Pol 2015;66:73-78.
58.
Pusztaszeri M, Wang H, Cibas ES, Powers CN, Bongiovanni M, Ali S, Khurana KK, Michaels PJ, Faquin WC: Fine-needle aspiration biopsy of secondary neoplasms of the thyroid gland: a multi-institutional study of 62 cases. Cancer Cytopathol 2015;123:19-29.
59.
Pugh JL, Jhala NC, Eloubeidi MA, Chhieng DC, Eltoum IA, Crowe DR, Varadarajulu S, Jhala DN: Diagnosis of deep-seated lymphoma and leukemia by endoscopic ultrasound-guided fine-needle aspiration biopsy. Am J Clin Pathol 2006;125:703-709.
60.
Eloubeidi MA, Varadarajulu S, Eltoum I, Jhala D, Chhieng DC, Jhala NC: Transgastric endoscopic ultrasound-guided fine-needle aspiration biopsy and flow cytometry of suspected lymphoma of the spleen. Endoscopy 2006;38:617-620.
61.
Zeppa P, Picardi M, Marino G, Troncone G, Fulciniti F, Vetrani A, Rotoli B, Palombini L: Fine-needle aspiration biopsy and flow cytometry immunophenotyping of lymphoid and myeloproliferative disorders of the spleen. Cancer 2003;99:118-127.
62.
Bonifacio A, Goldberg RE, Patterson BJ, Haider M: Flow-cytometry-enhanced fine-needle aspiration biopsy of the spleen. Can Assoc Radiol J 2000;51:158-162.
63.
Wang P, Yu XM: A primary nipple lymphoma diagnosed by a modified fine-needle aspiration method. Diagn Cytopathol 2012;40:719-723.
64.
Vigliar E, Cozzolino I, Fernandez LV, Di Pietto L, Riccardi A, Picardi M, Pane F, Vetrani A, Troncone G, Zeppa P: Fine-needle cytology and flow cytometry assessment of reactive and lymphoproliferative processes of the breast. Acta Cytol 2012;56:130-138.
65.
Mathiot C, Decaudin D, Klijanienko J, Couturier J, Salomon A, Dumont J, Vielh P: Fine-needle aspiration cytology combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesions. Diagn Cytopathol 2006;34:472-478.
66.
Levine PH, Zamuco R, Yee HT: Role of fine-needle aspiration cytology in breast lymphoma. Diagn Cytopathol 2004;30:332-340.
67.
Dahmoush L, Hijazi Y, Barnes E, Stetler-Stevenson M, Abati A: Adult T-cellleukemia/lymphoma: a cytopathologic, immunocytochemical, and flow cytometric study. Cancer 2002;96:110-116.
68.
Al Omran S, Mourad WA, Ali MA: Gamma/delta peripheral T-cell lymphoma of the breast diagnosed by fine-needle aspiration biopsy. Diagn Cytopathol 2002;26:170-173.
69.
Marshall CB, Jacob B, Patel S, Sneige N, Jimenez CA, Morice RC, Caraway N: The utility of endobronchial ultrasound-guided transbronchial needle aspiration biopsy in the diagnosis of mediastinal lymphoproliferative disorders. Cancer Cytopathol 2011;119:118-126.
70.
Zaer FS, Braylan RC, Zander DS, Iturraspe JA, Almasri NM: Multiparametric flow cytometry in the diagnosis and characterization of low-grade pulmonary mucosa-associated lymphoid tissue lymphomas. Mod Pathol 1998;11:525-532.
71.
Mehra M, Tamhane A, Eloubeidi MA: EUS-guided FNA combined with flow cytometry in the diagnoses of suspected or recurrent intrathoracic or retroperitoneal lymphoma. Gastrointest Endosc 2005;62:508-513.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.